Current Report Filing (8-k)
10 June 2023 - 6:16AM
Edgar (US Regulatory)
0001837412
false
0001837412
2023-06-05
2023-06-05
0001837412
SLGC:ClassCommonStock0.0001ParValuePerShareMember
2023-06-05
2023-06-05
0001837412
SLGC:WarrantsEachExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember
2023-06-05
2023-06-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 5, 2023
SomaLogic, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-40090 |
|
52-4298912 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
2945 Wilderness Place, Boulder, Colorado |
|
80301 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (303) 625-9000
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on
which registered |
Class A common stock, $0.0001 par value per share |
|
SLGC |
|
The NASDAQ Stock Market LLC |
Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share |
|
SLGCW |
|
The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 5, 2023, SomaLogic, Inc. (the “Company”)
held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders
voted on the three proposals described below.
The final results for each of the matters submitted
to a vote of stockholders at the Annual Meeting are as follows:
Item 1: Election of Class II directors
Name |
|
For |
|
Withheld |
|
Broker Non-Votes |
Troy Cox |
|
79,838,397 |
|
27,777,230 |
|
32,425,685 |
Kathy Hibbs |
|
94,632,738 |
|
12,982,889 |
|
32,425,685 |
Tycho Peterson |
|
107,175,310 |
|
440,317 |
|
32,425,685 |
Item 2: Ratification of Ernst & Young LLP as the Company’s
independent registered public accounting firm for the fiscal year ending December 31, 2023
For | | |
Against | | |
Abstentions | |
| 139,971,999 | | |
| 12,251 | | |
| 57,062 | |
Item 3: Approval of an amendment to the
Company’s Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance by 500,000 shares
For | | |
Against | | |
Abstentions | | |
Broker Non-Votes | |
| 107,280,741 | | |
| 262,534 | | |
| 72,352 | | |
| 32,425,685 | |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
June 9, 2023 |
SomaLogic, Inc. |
|
|
|
|
By: |
/s/ Ruben Gutierrez |
|
Name: |
Ruben Gutierrez |
|
Title: |
General Counsel |
CM Life Sciences II (NASDAQ:CMII)
Historical Stock Chart
From May 2024 to Jun 2024
CM Life Sciences II (NASDAQ:CMII)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about CM Life Sciences II Inc (NASDAQ): 0 recent articles
More Somalogic, Inc. News Articles